Success Story: Thanks to Our Assistance, NIW Approval for a Molecular Diagnostics Researcher Without Request for Evidence
Client’s Testimonial:
"Thank you so much for working with me.”
On August 27th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Chief Resident in the Field of Molecular Diagnostics (Approval Notice).
General Field: Molecular Diagnostics
Position at the Time of Case Filing: Chief Resident
Country of Origin: Poland
State of Residence at the Time of Filing: Virginia
Approval Notice Date: August 27th, 2026
Processing Time: 2 months, 22 days (Premium Processing Upgrade Requested)
Case Summary:
Neurological, endocrine, and other complex medical conditions present ongoing diagnostic and treatment challenges for clinicians and patients across the United States. We are proud to celebrate another successful EB-2 National Interest Waiver (NIW) approval for a client whose research applies advanced scientific and diagnostic methods to improve disease understanding, support more accurate clinical decision-making, and advance patient care. Filed with a later premium processing upgrade, the petition demonstrated that the client’s proposed endeavor possesses both substantial merit and national importance by contributing to precision medicine, improving diagnostic accuracy, reducing unnecessary procedures, and strengthening evidence-based healthcare.
Applying Molecular Diagnostics to Precision Medicine
Holding an M.D. in medicine, the client is currently employed as a chief resident at a U.S. medical institution, where he provides diagnostic services and conducts research related to molecular diagnostics, pathology, genomic analysis, and disease interpretation. His proposed endeavor involves applying advanced diagnostic and genomic approaches to improve the understanding, classification, and management of complex medical conditions.
Rather than limiting the work to a particular disease or clinical setting, we emphasized its broader relevance to precision medicine, public health, diagnostic innovation, and healthcare efficiency. By improving diagnostic frameworks and supporting more accurate risk assessment, the client’s work may help clinicians make better-informed decisions, enhance patient care, and reduce unnecessary interventions.
Building an Objective Record of Excellence
To establish that the client was well positioned to advance this endeavor, the petition documented a focused record of scholarly achievement that included 8 peer-reviewed journal articles (4 of which were first-authored), 3 abstracts (including 2 first-authored abstracts), 2 journal articles under review, and 43 citations to the client’s published work.
The petition documented the client’s service on a professional research committee, where his responsibilities included reviewing submitted abstracts and helping select recipients for research-related honors and awards. This evidence helped show that the client’s expertise was recognized within the field.
The petition also showed that 2 of the client’s papers ranked among highly cited Molecular Biology and Genetics articles for their respective publication years, including 1 paper in the top 1% and 1 paper in the top 20%. This comparative evidence helped demonstrate that the client’s work had attracted attention beyond ordinary publication.
Demonstrating National Importance
North America Immigration Law Group (NAILG) structured the petition by connecting the client’s prior research accomplishments with a clearly defined future research agenda. We demonstrated that the proposed endeavor extends beyond individual clinical projects by advancing diagnostic tools and analytical approaches that may improve disease classification, strengthen risk assessment, reduce unnecessary procedures, and support precision medicine.
The petition also highlighted research support from the National Institutes of Health (NIH), including the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging (NIA), and the National Cancer Institute (NCI), as well as support from the Epilepsy Foundation and other scientific research programs. This funding provided additional objective evidence that the client’s research areas were connected to nationally important efforts in disease understanding, diagnosis, and patient care.
Looking Ahead
The approval of this NIW petition recognizes the importance of combining molecular diagnostics, genomic analysis, and clinical pathology to improve the diagnosis and management of complex diseases. Through objective evidence of scholarly achievement, professional recognition, expert support, research funding, and a nationally significant proposed endeavor, we successfully demonstrated that the client’s continued work will contribute meaningfully to precision medicine and evidence-based healthcare in the United States.